|
CTPS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.073640E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.877700E-02 |
| Normal-vs-Stage2 |
2.392200E-01 |
| Normal-vs-Stage3 |
2.615600E-01 |
| Normal-vs-Stage4 |
7.657700E-02 |
| Stage1-vs-Stage2 |
7.694000E-01 |
| Stage1-vs-Stage3 |
4.527400E-01 |
| Stage1-vs-Stage4 |
9.065600E-01 |
| Stage2-vs-Stage3 |
7.705200E-01 |
| Stage2-vs-Stage4 |
7.284200E-01 |
| Stage3-vs-Stage4 |
4.601000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.562790E-01 |
| Normal-vs-AfricanAmerican |
9.422100E-03 |
| Normal-vs-Asian |
2.625200E-01 |
| Caucasian-vs-AfricanAmerican |
2.708000E-02 |
| Caucasian-vs-Asian |
2.862200E-01 |
| AfricanAmerican-vs-Asian |
4.450200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.904600E-01 |
| Normal-vs-Female |
1.578200E-03 |
| Male-vs-Female |
1.076320E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.874210E-01 |
| Normal-vs-Age(41-60Yrs) |
8.883700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.006000E-02 |
| Normal-vs-Age(81-100Yrs) |
3.461600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.794600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.111600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.192210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.862800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.281800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.705660E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.395370E-01 |
| Normal-vs-Grade 2 |
2.145800E-02 |
| Normal-vs-Grade 3 |
8.940000E-02 |
| Normal-vs-Grade 4 |
7.791700E-02 |
| Grade 1-vs-Grade 2 |
7.298400E-03 |
| Grade 1-vs-Grade 3 |
2.279700E-02 |
| Grade 1-vs-Grade 4 |
7.465600E-02 |
| Grade 2-vs-Grade 3 |
4.456800E-01 |
| Grade 2-vs-Grade 4 |
5.637600E-01 |
| Grade 3-vs-Grade 4 |
8.650600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.002000E-02 |
| Normal-vs-ccB subtype |
4.228300E-02 |
| ccA subtype-vs-ccB subtype |
5.945600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.183800E-03 |
| Normal-vs-N1 |
1.643150E-01 |
| N0-vs-N1 |
9.735600E-01 |
|
|
